Table 1 Relationship between the protein expression of SLC6A14 and clinicopathologic characteristics of colon cancer
From: Blockade of the amino acid transporter SLC6A14 suppresses tumor growth in colorectal Cancer
Group | Number of cases | H scores | t or F value | P value |
|---|---|---|---|---|
Pathological type | ||||
Normal mucosa | 94 | 63.26 ± 2.82 | 16.516 | <0.001** |
Adenoma | 65 | 54.96 ± 3.77 | ||
Colon cancer | 302 | 83.15 ± 2.26 | ||
Other types (liver cancer) | 21 | 57.14 ± 9.78 | ||
Age (year-old) | ||||
≤ 60 | 90 | 82.07 ± 3.85 | ||
> 60 | 212 | 83.93 ± 2.75 | 0.378 | 0.706 |
Gender | ||||
Male | 168 | 86.33 ± 3.05 | ||
Female | 134 | 79.67 ± 3.29 | 1.476 | 0.141 |
Tumor size (cm) | ||||
≤ 5 | 192 | 80.76 ± 2.75 | ||
> 5 | 110 | 87.94 ± 3.85 | 1.544 | 0.124 |
Tumor location | ||||
Colon | 182 | 81.33 ± 2.93 | ||
Rectum | 120 | 86.47 ± 3.51 | 1.120 | 0.264 |
Differentiation | ||||
Well-differentiated | 28 | 67.05 ± 6.24 | ||
Moderately-differentiated | 153 | 76.25 ± 3.00 | ||
Poorly-differentiated | 121 | 95.60 ± 3.64 | 11.556 | <0.001** |
Clinical stage | ||||
I + II | 84 | 69.79 ± 4.37 | ||
III + IV | 218 | 97.81 ± 2.92 | −4.962 | <0.001** |